Literature DB >> 18728972

Immunohistochemical analyses of phosphatases in childhood B-cell lymphoma: lower expression of PTEN and HePTP and higher number of positive cells for nuclear SHP2 in B-cell lymphoma cases compared to controls.

Marie Fridberg1, Sofia Kjellström, Lola Anagnostaki, Ingela Skogvall, Tomas Mustelin, Thomas Wiebe, Jenny L Persson, Michael Dictor, Anette Gjörloff Wingren.   

Abstract

Although many pediatric B-cell lymphoma patients are being cured today, much is still unknown about the pathogenesis of this disease. Protein tyrosine phosphatases are involved in the control of survival, growth, and differentiation of cells. The authors have analyzed 26 pediatric B-cell lymphoma cases for the expression of a panel of phosphatases and report a statistically significant lower expression intensity of PTEN and HePTP and higher nuclear SHP2 expression in B-cell lymphoma cases compared to lymphoid tissue. Knowledge about the expression of key regulatory proteins in pediatric B-cell lymphomas is necessary for revealing the complex molecular background of this disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18728972     DOI: 10.1080/08880010802237054

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  7 in total

1.  Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family.

Authors:  Xu Li; Kim My Tran; Kathryn E Aziz; Alexey V Sorokin; Junjie Chen; Wenqi Wang
Journal:  Mol Cell Proteomics       Date:  2016-07-18       Impact factor: 5.911

Review 2.  Inside the human cancer tyrosine phosphatome.

Authors:  Sofi G Julien; Nadia Dubé; Serge Hardy; Michel L Tremblay
Journal:  Nat Rev Cancer       Date:  2011-01       Impact factor: 60.716

3.  The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma.

Authors:  Chengying Jiang; Fangke Hu; Yanhong Tai; Jingli Du; Beibei Mao; Zengqiang Yuan; Yan Wang; Lixin Wei
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-07       Impact factor: 4.553

4.  PTPN14 is required for the density-dependent control of YAP1.

Authors:  Wenqi Wang; Jun Huang; Xin Wang; Jingsong Yuan; Xu Li; Lin Feng; Jae-Il Park; Junjie Chen
Journal:  Genes Dev       Date:  2012-09-01       Impact factor: 11.361

5.  Low expression of SHP-2 is associated with less favorable prostate cancer outcomes.

Authors:  Helena Tassidis; Leon J S Brokken; Karin Jirström; Anders Bjartell; David Ulmert; Pirkko Härkönen; Anette Gjörloff Wingren
Journal:  Tumour Biol       Date:  2012-11-29

6.  Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer.

Authors:  Fuqin Su; Fangli Ren; Yu Rong; Yangmeng Wang; Yongtao Geng; Yinyin Wang; Mengyao Feng; Yanfang Ju; Yi Li; Zhizhuang J Zhao; Kun Meng; Zhijie Chang
Journal:  Breast Cancer Res       Date:  2012-03-06       Impact factor: 6.466

7.  Increased PTPRA expression leads to poor prognosis through c-Src activation and G1 phase progression in squamous cell lung cancer.

Authors:  Zhidong Gu; Xuqian Fang; Chang Li; Changqiang Chen; Guangshu Liang; Xinming Zheng; Qishi Fan
Journal:  Int J Oncol       Date:  2017-06-23       Impact factor: 5.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.